Company

Travin

Rocket Ship Rating

Rocket Ship Rating: 20 out of 100

Record updated 1 October 2026

About

Develops blood-brain barrier shuttles of RNA therapeutics using its multiplexed in vivo screening platform, initially for Dravet syndrome.

Investor VC firms in this preview

VC firm names are a sample from VC Catalog’s database and may be incomplete. A database connection is not a guarantee of an introduction.